- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 501/24 - 7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
Patent holdings for IPC class C07D 501/24
Total number of patents in this class: 17
10-year publication summary
|
2
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gladius Pharmaceuticals Corporation | 4 |
2 |
| Orchid Chemicals & Pharmaceuticals Limited | 34 |
2 |
| Merck Sharp & Dohme LLC | 3734 |
2 |
| The Board of Trustees of the Leland Stanford Junior University | 6652 |
1 |
| DSM Sinochem Pharmaceuticals Netherlands B.V. | 60 |
1 |
| Newsouth Innovations Pty Limited | 621 |
1 |
| Nippon Chemical Industrial Co., Ltd. | 292 |
1 |
| Shionogi & Co., Ltd. | 873 |
1 |
| The Texas a & M University System | 1866 |
1 |
| University of Wollongong | 93 |
1 |
| Ventana Medical Systems, Inc. | 1068 |
1 |
| Zoetis LLC | 45 |
1 |
| Hng Chembio Pharmacy Co., Ltd. | 2 |
1 |
| Nectar Lifesciences Limited | 6 |
1 |
| Other owners | 0 |